Adenoid Cystic Carcinoma clinical trials
12 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial
- A Study of Enfortumab Vedotin in People With Adenoid Cystic Carcinoma
- CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC
- Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Carcinoma Subtype I (ACC-I)
- A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers
- Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)
- Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma
- Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers
- A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
- A Study of CRD3874-SI in People With Solid Tumors
- Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Adenoid Cystic Carcinoma” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.